Abstract | AIM AND OBJECTIVE: MATERIALS AND METHODS: Patients with hepatitis B virus (HBV)-induced HCC, 100 without and 30 with a bacterial infection, and 30 healthy adult controls were enrolled retrospectively. Baseline clinical data collected before treatment with transarterial chemoembolization (TACE) was evaluated, and serglycin expression was assayed by flow cytometry. Receiver operating characteristic (ROC) curve analysis identified serglycin cutoff values for patient stratification. Cox regression and Kaplan-Meier analyses were performed to identify predictors of overall survival (OS). RESULTS: CONCLUSION: The intensity of serglycin fluorescence in peripheral neutrophils was independently predictive of survival in HCC, and its value was not limited by a bacterial infection. The method presented here is a simple and feasible way to predict prognosis in HCC patients with TACE.
|
Authors | Yue Li, Hongjie Chen, Huiqiong Lu, Zengcheng Zou, Yongwei Li |
Journal | Combinatorial chemistry & high throughput screening
(Comb Chem High Throughput Screen)
Vol. 24
Issue 7
Pg. 986-995
( 2021)
ISSN: 1875-5402 [Electronic] United Arab Emirates |
PMID | 33081679
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at [email protected]. |
Chemical References |
- Proteoglycans
- Vesicular Transport Proteins
- serglycin
|
Topics |
- Carcinoma, Hepatocellular
(diagnosis, drug therapy, metabolism)
- Chemoembolization, Therapeutic
- Female
- Hematopoietic Stem Cells
(metabolism)
- Humans
- Liver Neoplasms
(diagnosis, drug therapy, metabolism)
- Male
- Middle Aged
- Proteoglycans
(genetics, metabolism)
- Retrospective Studies
- Vesicular Transport Proteins
(genetics, metabolism)
|